GLMD
Galmed Pharmaceuticals Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$3.88
−1.02%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-89.0%
Return on equity
-62.0%
Return on assets
-77.4%
Return on invested capital
0.00x
Asset turnover
-$8.5M
Cash from operations
$11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026